Inventor · disambiguated record
Bore G. Raju
Also filed as: RAJU BORE G · RAJU BORE GOWDA
19 granted patents·5 pending applications·975 citations·filing 1993–2005
97Inventor score
Files withTEXAS BIOTECHNOLOGY CORP14IMMUNOPHARMACEUTICS INC2PFIZER1TEXAS BIOTECHNOLOGY1TEXAS BIOTECHNOLOGY CORP INC1
Top patents by PatentIndex Score
24 records- 0197US5571821ASulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Nov 5, 1996·125 cites·91 claims
- 0295US5594021AThienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1995·Granted Jan 14, 1997·88 cites·174 claims
- 0395US5514691AN-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelinIMMUNOPHARMACEUTICS INC·Filed 1993·Granted May 7, 1996·128 cites·94 claims
- 0495US5464853AN-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelinIMMUNOPHARMACEUTICS INC·Filed 1993·Granted Nov 7, 1995·100 cites·25 claims
- 0592US5962490AThienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Oct 5, 1999·93 cites·97 claims
- 0688US5977117ASubstituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Nov 2, 1999·72 cites·73 claims
- 0788US5591761AThiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Jan 7, 1997·67 cites·93 claims
- 0881US6541498B2Benzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY·Filed 2000·Granted Apr 1, 2003·15 cites·43 claims
- 0981US6194448B1N, N-disubstituted amides that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Feb 27, 2001·42 cites·17 claims
- 1078US6632829B2Sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Oct 14, 2003·9 cites·55 claims
- 1178US6420567B1N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1997·Granted Jul 16, 2002·32 cites·73 claims
- 1277US6030991ABenzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Feb 29, 2000·47 cites·125 claims
- 1376US6265428B1Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 24, 2001·34 cites·14 claims
- 1475US7691843B2N-hydroxyamide derivatives possessing antibacterial activityPFIZER·Filed 2003·Granted Apr 6, 2010·9 cites·23 claims
- 1575US6331637B1N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Dec 18, 2001·26 cites·60 claims
- 1674US6096773ACompounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP INC·Filed 1999·Granted Aug 1, 2000·33 cites·10 claims
- 1773US6342610B2N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jan 29, 2002·18 cites·52 claims
- 1866US6262084B1Compounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 17, 2001·18 cites·10 claims
- 1960US6376523B1Benzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Apr 23, 2002·19 cites·97 claims
- 2055US2003208084A1Sulfonamides and derivatives thereof that modulate the activity of endothelinFiled 2003·Application pending·0 cites
- 2155US2001014694A1Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelinFiled 2001·Application pending·0 cites
- 2249US2003109583A1Administration of negamycin or deoxynegamycin for the treatment of bacterial infectionsFiled 2002·Application pending·0 cites
- 2337US2006211603A1Ramoplanin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2005·Application pending·0 cites
- 2436US2003125389A1Beta-amino acid derivatives useful for the treatment of bacterial infectionsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →